|
Market Closed -
Euronext Paris
16:55:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 18.60 EUR | +3.91% |
|
+5.68% | -38.61% |
| 09-17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 323M 363M 299M 272M 514M 34.48B 522M 3.6B 1.41B 17.99B 1.36B 1.33B 57.36B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 275M 309M 255M 232M 438M 29.37B 445M 3.06B 1.2B 15.33B 1.16B 1.14B 48.86B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
CBOE
| BOIp | Real-time | |
Boerse Muenchen
| BON | Real-time | |
Börse Stuttgart
| BON | Delayed | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time |
| 1 day | +3.91% | ||
| 1 week | +5.68% | ||
| Current month | -7.00% | ||
| 1 month | -26.19% | ||
| 3 months | -30.60% | ||
| 6 months | -26.19% | ||
| Current year | -38.61% |
| 1 week | 16.9 | 19.5 | |
| 1 month | 16.9 | 21.5 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 43.96 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 31/12/2024 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 30/06/2011 |
| Director/Board Member | 54 | 09/03/2010 | |
| Director/Board Member | 51 | 22/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/10/23 | Sell | Director | 198,664 | 1.1323% | ||
| 29/10/23 | Sell | Director | 462,964 | 2.6387% | ||
| 29/10/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.91% | +5.68% | -32.36% | -64.57% | 363M | ||
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | ||
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | ||
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | ||
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | ||
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | ||
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | ||
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | ||
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | ||
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | ||
| Average | +0.23% | +3.82% | +27.73% | +48.67% | 394.13B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.33% | +71.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 548M 452M 411M 776M 52.06B 788M 5.43B 2.13B 27.17B 2.06B 2.01B 86.6B | 501M 564M 464M 423M 797M 53.5B 810M 5.58B 2.19B 27.92B 2.12B 2.07B 89B |
| Net income | 11.34M 12.75M 10.51M 9.56M 18.04M 1.21B 18.33M 126M 49.52M 632M 47.86M 46.84M 2.01B | 32.64M 36.72M 30.26M 27.53M 51.95M 3.49B 52.78M 364M 143M 1.82B 138M 135M 5.8B |
| Net Debt | -49.74M -55.95M -46.1M -41.94M -79.15M -5.31B -80.42M -554M -217M -2.77B -210M -206M -8.83B | -47.86M -53.84M -44.36M -40.36M -76.15M -5.11B -77.37M -533M -209M -2.67B -202M -198M -8.5B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | €18.60 | +3.91% | 9,099 |
| 15/10/26 | €17.90 | -0.56% | 5,955 |
| 14/10/26 | €18.00 | +6.51% | 4,223 |
| 13/10/26 | €16.90 | -2.03% | 13,940 |
| 12/10/26 | €17.25 | -1.99% | 7,127 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















